Skip to main content

User account menu

  • Log in
  • Register
  • Contact
BandwidthHigh

Language switcher

  • English
  • Français
  • Español

Main navigation

    • About us
    • Our work
    • Rationale
    • IDDO Team
    • Jobs
    • Contact us
    • Our partners
    • Governance
    • IDDO Board
    • Data Access Committee
    • Data sharing
    • Contributing data
    • Accessing data
    • IDDO data sharing registrations
    • Research themes
    • COVID-19
    • Ebola
    • Malaria
    • Visceral leishmaniasis
    • Medicine Quality
    • Antimicrobial Resistance
    • Schistosomiasis & STHs
    • Chagas Disease
    • Febrile illness
    • Scrub typhus
    • Other diseases
    • Research
    • Malaria Tracking Resistance
    • Malaria Clinical Trials Toolkit
    • COVID-19 LSR Tool
    • VL Tool
    • Medicine Quality Monitoring Globe
    • Medicine Quality Scientific Literature Surveyor
    • Febrile Illness Surveyor
    • Publications
    • Tools & resources
  • News

WWARN News

Please visit WWARN's website for regular updates on malaria and sign up for the WWARN newsletter here. 

Credit: Pearl Gan
MQRG and MORU teams working on evaluation of portable devices
Friday, 8 October 2021

Lack of evidence is key barrier to using portable devices to detect poor quality medicines

A series of papers which reviewed portable devices to detect poor quality medicines has concluded major gaps in scientific evidence remain a key barrier for regulators to implement surveillance systems using such devices.
Health worker sorts prescriptions
Tuesday, 21 September 2021

New study alerts to the risk of poor quality medicines used to prevent and treat cardiovascular disease

A new study suggests there are important but neglected issues with substandard and falsified (SF*) medicines and medical products used to prevent and treat cardiovascular diseases.
Group of children
Monday, 20 September 2021

Open call to join new studies launched by the VL research community

Two new Study Groups, a collaboration between IDDO and the global visceral leishmaniasis (VL) research community, have been formed to answer specific research questions about treatments. They will undertake individual patient data meta-analyses using datasets from multiple studies, across sub-popula...
Man and woman in doctor's office
Monday, 13 September 2021

Systematic review identifies research gaps for Chagas disease

A new, large-scale systematic review published today in PLOS Neglected Tropical Diseases has identified clear, significant research gaps in the diagnosis and treatment of Chagas disease.
Global map
Thursday, 2 September 2021

IDDO to share latest research at ECTMIH 2021

Join the IDDO team who will be presenting at the 12th European Congress on Tropical Medicine and International Health (ECTMIH) between 28 September to 1 October. ECTMIH provides a platform for experts, scientists and researchers to present scientific developments and breakthroughs in tropical medici...
mother and baby at clinic
Wednesday, 11 August 2021

The scale of the problem of VL in pregnancy is underestimated

A new systematic review published today in PLOS Neglected Tropical Diseases has found that reports on the occurrence of Visceral Leishmaniasis (VL) in pregnant women are rare in published literature, are not systematically captured, and cases are rarely followed-up to detect the consequences of infe...
Blurred people on a busy street
Thursday, 29 July 2021

Preprints: it’s time to agree on terminology and best practice

Preprints are increasingly being used to share manuscripts that are not yet peer-reviewed to enable the rapid dissemination of research findings. In particular, they have also become an important source of information for wider, non-specialist audiences keen to follow COVID-19 research developments,...
pills
Friday, 23 July 2021

Track regulatory and WHO alerts on our substandard and falsified medical products tool

Substandard and falsified (SF*) medical products, including medicines, vaccines, diagnostic tests and medical devices are critical global public health issues and current SF surveillance in most of the world is extremely limited. Information sharing on SF incidents is very poor. Our Medicine Quality...
BSP 2021 logo
Thursday, 20 May 2021

Join IDDO at this year’s BSP Conference in June

This year’s BSP Conference will run across two streams: the usual science stream with its mix of varied high quality themed scientific sessions, keynote speakers and presentations by postgraduate and postdoctoral researchers, and a second, specialist stream which will include a series of talks from ...
ANTICOV logo
Tuesday, 27 April 2021

ANTICOV: largest clinical trial in Africa for people with mild COVID-19 to test new drug combination

27 APRIL 2021 – The ANTICOV clinical trial, conducted in 13 African countries, has started the recruitment of participants to test a new drug combination, nitazoxanide + ciclesonide, to treat people with mild-to-moderate COVID-19 before their cases become severe.
Female patient getting a medical check-up
Monday, 29 March 2021

Risks of serious adverse events following treatment for visceral leishmaniasis

The results of a large-scale systematic review and meta-analysis have published in PLOS Neglected Tropical Diseases. This research aimed to collate all reported serious adverse events (SAE) in visceral leishmaniasis (VL) clinical trials and quantify the incidence of mortality during the first 30 day...
Professor Philippe Guérin
Monday, 29 March 2021

Calls for clarity on pooled evidence in COVID-19 therapeutic reviews and guidelines

IDDO’s Director, Professor Philippe Guérin, has co-authored a letter published in The Lancet drawing attention of the risk of pooling data from uncomplicated illness and more severe ill hospitalised patients in the development of COVID-19 treatment guidelines. Although SARS-CoV-2 is one virus, the C...
mother_and_baby.credit_dominic_chavez_world_bank.jpg
Thursday, 18 March 2021

Researchers call for access to Ivermectin for young children

Millions of children weighing less than 15kg are currently denied access to Ivermectin treatment due to insufficient safety data being available to support a change to the current label indication. The WorldWide Antimalarial Resistance Network (WWARN)’s new meta-analysis published today provides evi...
Girls at clinic
Wednesday, 17 March 2021

Gender imbalance in visceral leishmaniasis clinical trials

Researchers have found that despite an ongoing trend for a decreasing proportion of males being enrolled in antileishmanial therapeutic efficacy trials over time, there are still 1.8 times as many males as females involved in clinical trials. A new systematic review and meta-analysis published today...
Gloved hand holding syringe inserted into small vial
Tuesday, 16 March 2021

New report highlights growing concern of vaccine falsification

The Medicine Quality Research Group has published a new Medical Product Quality Report focussing on increasing issues around substandard and falsified (SF) COVID-19 vaccines. With the implementation of the key innovations of COVID-19 vaccines, there have been growing numbers of reports of SF vaccine...
Children eating
Friday, 26 February 2021

Applications for RSTMH 2021 grants open

The small grants programme offers early career researchers and global health professionals based anywhere in the world the opportunity to apply for funding in a topic related to tropical medicine and global health. The programme funds projects across the research spectrum, including lab-based, clini...
credit_rama_george-alleyne_world_bank.jpg
Friday, 12 February 2021

Evidence supports WHO recommendation for PQ combined with ACTs to block Plasmodium falciparum transmission

Evidence from a new study, initiated by the Primaquine Roll Out Group and conducted at WWARN, supports the World Health Organization (WHO) recommendation for use of 0.25mg/kg dose of primaquine (PQ) combined with artemisinin-based combination therapies (ACT) to block Plasmodium falciparum transmissi...
Geneva Health Forum logo
Thursday, 4 February 2021

Geneva Health Forum panel on the elimination of NTDs and the new WHO Roadmap

The WHO 2030 NTD Roadmap has just been launched and a recent Geneva Health Forum panel took that as its starting point to discuss the possibility of eliminating neglected tropical diseases (NTDs). IDDO’s Director, Professor Philippe Guérin joined co-panellists Dr Amy Fall, the Global Health Medi...
lab_testing_ctredit.trinn_suwannapha_worldbank.jpg
Wednesday, 13 January 2021

Check-list recommended to improve reporting of microscopy methods and results in malaria studies

A study to explore the variations of how microscopy methods are reported in published malaria studies has recommended standardised procedures should be implemented for methodological consistency and comparability of clinical trial outcomes.
Prof. P. Claver Kayumba
Wednesday, 2 December 2020

Tribute to the Memory of Prof. P. Claver Kayumba, University of Rwanda

It is with great sadness that IDDO has learnt of the death of Professor P. Claver Kayumba, who latterly coordinated academic and professional education programs at the EAC Regional Center of Excellence for Vaccines, Immunization and Health Supply Chain Management (RCE-VIHSCM), hosted by the Universi...

Pagination

  • First page « First
  • Previous page ‹‹
  • Page 1
  • Page 2
  • Current page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page ››
  • Last page Last »
Sign up for our newsletter Twitter LinkedinIDDO on YoutubeRSS

Footer menu

  • Cookies
  • Privacy Notice
  • Accessibility
  • Sitemap
  • Terms of use
© 2023 Infectious Diseases Data Observatory